CAELYX ® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

Condition:   Breast Cancer Intervention:   Drug: Caelyx® Sponsors:   European Institute of Oncology;   Janssen-Cilag International NV Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials